Sort by
Refine Your Search
-
Category
-
Program
-
Field
-
related to biomedical sciences, with preference for experience in physiology or cardiovascular sciences; Experience with (endothelial or cardiac) cell culture, protein biochemistry, in vitro models using
-
with: A master’s degree in a field related to biomedical sciences, with preference for experience in physiology or cardiovascular sciences; Experience with (endothelial or cardiac) cell culture, protein
-
, in parallel, explore CRISPR and AAV technologies to develop new ocular gene therapy. We have all multidisciplinary facilities, technology and expertise needed directly at our disposal. The candidate
-
: Finished PhD in a field related to neuroscience, immunology, tissue engineering and/or iPSC organoid culture; Experience with in vitro models using iPSC technology and gene editing (i.e. Crispr/Cas) is a
-
. Although we achieved a high level of standardization, the complexity of the assay and technology as well as the thriving research field require continuous improvements of the used hardware (electronics
-
result in new fundamental knowledge leading to improved interpretation of imaging datasets, relevant for the clinical setting. We are looking for an enthusiastic, skilled and creative postdoctoral
-
on the cytokine responses of macrophages; Next to cell culture experiments, you will use and analyze state-of-the-art approaches such as RNA-sequencing and ChIP-sequencing analysis; Translate your findings
-
of Twente and Wageningen, to detect RNA biomarkers with CRISPR-Cas13. This technology is ultra-sensative and may revolutionize ‘point of care ‘cancer diagnostics. You will work with state-of-the-art
-
treatment technology for applying and monitoring effective novel personalized breast cancer treatments combining MR-guided local thermotherapy with ‘smart’ nano-chemotherapy. This project is supported by a
-
sciences or biology; Experience with iPSC models and/or extensive cell culture experience with other cell types; Hands-on experience with CRISPR or assay development is an advantage, but not required